Transmission (Vertical)

Deaths Prompt Concern Over HIV Drug Combinations

Published in AIDS Weekly, February 15th, 1999

The death of two children in a French AIDS study has raised possible concerns about drug combinations used to prevent HIV infected mothers from passing the virus to their babies during birth.

The use of the drug AZT to stop mother-to-child transmission of HIV often is cited as one of the greatest successes in efforts against AIDS. The drug can halve the risk of vertical transmission of HIV, which is typically around 20 percent to 25 percent. Since AZT's benefits in this area were shown five years ago, doctors in the United States and France largely have switched to using AZT in combination with 3TC, a similar AIDS drug, for pregnant women.

Dr....

Want to see the full article?

Purchase this article for only $3.00

We're a pay-per-view site for premium content. If you'd like to purchase this article, it's only $3.00.

Welcome to NewsRx!

Learn more about a six-week, no-risk free trial of AIDS Weekly

Source: AIDS Weekly (1999-02-15)

NewsRx is Social

Top Medical Newsletters

Awards

Best Health/Healthcare Content, 2012
Best Health/Healthcare Content, 2011
Best e-Business Site, 2010
Best e-Business Site, 2009
Best e-Business Site, 2008
Best e-Business Site, 2007
Best e-Business Site, 2006
Best Healthcare Content, 2005
Best Overall Internet Site, 2005
Best Interactive Site, 2005

Facts & Stats

NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.

Google 2010 PageRank: #2 Among Top Health News and Media Publications
Google 2010 PageRank: #2 Among Top Science Publications in Biology/Physiology
Google 2010 PageRank: #2 Among Top News and Media for the Business of Pharmaceuticals
Amazon's Alexa 2010 PageRank: #2 News and Media Site for the Pharmaceutical Industry